4Barton SE, Ebel CE, Kirchner JT, et al. The clinical management of recurrent genital herpes: current issues and future prospects [J]. Herpes, 2002, 9(1): 15-20.
5Ashley RL, Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology[J]. Clin Microbiol Rev, 1999, 12(1):1-8.
6Nandi P, Das K, Kumari HP, et al. Study to determine the preva?lence of herpes simplex virus type II antibody in female genital tract lesion patients in a district of Andhra Pradesh, India[J]. J BAMR, 2013, 3(1):147-155.
7Levi M, Ruden U, WahrenA. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV -2) and HSV-l antibodiesllJ. ClinDiagnLab Immunol, 1996,3(3)-265- 269.
8Patel R, Green J, Clarke E, et al. 2014 UK national guideline for the management of anogenital herpes[EB/OL].[2015-03-15]. http://www.bashh.orgldocuments/HSV%20Final%20guidelines%20 with %20ref%20sorted. pdf.
9Buchacz K, McFarland W, Hernandez M, et al. Prevalence and co?rrelates of herpes simplex virus type 2 infection in a popula?tion-based survey of young women in low-income neighborhoods of Northern California. The Young Women's Survey Team[J]. Sex Transm Dis, 2000, 27(7):393-400.
10Wald A, Corey L, Cone R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclorir treatment[}].] Clin Invest, 1997, 99(5):1092-1097.
